CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 23,164	$ 8,555
Restricted cash	7,009	4,250
Investments in debt securities	29,645	31,365
Investments in partnerships (includes $349,362 and $296,855 pledged as collateral at March 31, 2020 and December 31, 2019, respectively)	368,598	316,677
Deferred tax assets, net	59,394	57,711
Loans held for investment (includes zero and $53,600 of related party loans at March 31, 2020 and December 31, 2019)	1,271	54,100
Other assets	18,991	12,984
Total assets	508,072	485,642
LIABILITIES AND EQUITY
Debt	223,653	201,816
Accounts payable and accrued expenses	4,300	2,527
Other liabilities	2,450	174
Total liabilities	230,403	204,517
Commitments and contingencies (see Note 10)
Preferred shares:
Preferred shares, no par value, 5,000,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019
Common shareholders' equity:
Common shares, no par value, 50,000,000 shares are authorized (5,702,423 and 5,701,946 shares issued and outstanding and 104,916 and 103,069 non-employee directors' deferred shares issued at March 31, 2020 and December 31, 2019, respectively)	270,489	273,492
Accumulated other comprehensive income ("AOCI")	7,180	7,633
Total shareholders’ equity	277,669	281,125
Total liabilities and equity	$ 508,072	$ 485,642